One nice little detail is the pick-up of the Chinese rights from Nova Vita. On top of the European, USA & Canada rights. Revenue targets $5-7.5 mil PA by 2010 - and thats on top of Termilone revenues kicking in 2008-2009.
BPO Price at posting:
0.0¢ Sentiment: Hold Disclosure: Held